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Abstract 1 
Aim: Lactoferrin and lactoperoxidase have antimicrobial effects against oral pathogens. 2 
This randomized, double-blinded, placebo-controlled parallel group study tested the 3 
efficacy of lactoferrin and lactoperoxidase-containing tablet (LF + LPO tablet) in 4 
improving the oral hygiene status of older individuals.  5 
Methods: Forty-six subjects (31 nursing home residents and 15 healthy older 6 
individuals) were randomly assigned to receive either LF + LPO or placebo tablets, and 7 
were asked to suck on a tablet after every meal for 8 weeks. Oral and bacteriological 8 
assessments were conducted at baseline, 4 weeks and 8 weeks.  9 
Results: Thirty-seven subjects (test group n= 20; mean age, 80.4 ± 6.4 years; placebo 10 
group n= 17; mean age, 85.9 ± 6.7 years) were included in the efficacy analysis. In the 11 
test group, the total number of bacteria in the tongue coating was significantly reduced 12 
at 4 and 8 weeks compared with that at baseline, and the number of Porphyromonas 13 
gingivalis and Fusobacterium nucleatum was significantly reduced at 8 weeks. The total 14 
number of bacteria and the number of P. gingivalis in the supra-gingival plaque were 15 
significantly reduced at 8 weeks. Moreover, there was a significant difference in the 16 
change in the number of P. gingivalis in supra-gingival plaque at 8 weeks between the 17 
two groups.  18 
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Conclusions: LF + LPO tablet ingestion exhibited antibacterial effects on periodontal 1 
bacteria present in the tongue coating and supra-gingival plaque, indicating that 2 
long-term ingestion may improve the oral hygiene of older individuals. 3 
 4 
Keywords: Lactoferrin, Lactoperoxidase, Older individuals, Periodontal bacteria, 5 
Randomized clinical trial 6 
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Introduction 1 
In 2015, the aging rate in Japan is 25.9%.1 Pneumonia is the third largest cause of 2 
death in the country, with mortality rates among older individuals continuing to rise.2 It 3 
has been reported that aspiration pneumonia forms more than 70% of all pneumonias 4 
affecting individuals over 70 years of age.3 It results in oropharyngeal secretions, 5 
including food and oral bacteria, and the main causative bacteria are oral anaerobic 6 
bacteria such as periodontal bacteria, and pneumococcus. Oral care lowers the risk of 7 
disease in older individuals at high risk of aspiration pneumonia.4 The importance of 8 
maintaining and improving oral hygiene has also been recognized by medical and 9 
nursing care.  10 
In this study, we focused on the role of multifunctional proteins lactoferrin (LF) 11 
and lactoperoxidase (LPO) present in food for the ma ntenance and improvement of 12 
health and oral hygiene of older individuals. LF is an 80 kDa iron-binding glycoprotein 13 
present in milk and is a component of exocrine secretions, blood plasma, and secondary 14 
granules of neutrophils.5 It has a diverse range of biological properties,6 and 15 
antibacterial and immunoregulatory actions.7 It has been reported that LF is also an 16 
inhibitor of biofilm and periodontitis bacteria,8 and suppresses the growth of Candida 17 
albicans in vitro.9  18 
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LPO is a heme-containing glycoprotein present in the exocrine secretions of 1 
mammals containing thiocyanate ions such as saliva, milk, tears, and airway mucus. It 2 
catalyzes the hydrogen peroxide-dependent oxidation of thiocyanate (SCN−) to 3 
hypothiocyanite (OSCN−), resulting in its antimicrobial properties. This is known as the 4 
LPO system and has been reported to exhibit a bactericidal effect on periodontal 5 
pathogenic bacteria and reduce oral malodor.10, 11 Although there are several clinical 6 
trials investigating oral malodor and periodontal disease,12, 13 there are very few that 7 
focus on older individuals. This study was a randomized, double-blinded, 8 
placebo-controlled, parallel group comparative clinical trial, where clinical and 9 
bacteriological assessment was conducted to examine the effects of continued ingestion 10 
of LF and LPO-containing tablets (LF + LPO tablets) on the oral hygiene of older 11 
individuals. 12 
 13 
Materials and Methods 14 
Study Design 15 
This was a single center, randomized, double-blinded, placebo-controlled, parallel 16 
group comparative study conducted in Japan. The study was conducted in accordance 17 
with Helsinki Declaration of 1975 and as revised in 2013. The study design was 18 
reviewed and approved by the research ethics committee of the School of Dentistry, 19 
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Showa University (no. 2014-016). This study was enrolled in the UMIN clinical trial 1 
registration system (ID: UMIN000015706). 2 
 3 
LF + LPO Tablet 4 
The total weight of LF + LPO tablet was 1.0 g. This LF + LPO tablet was readily 5 
soluble perforated type in order to prevent the asphyxia and aspiration. This LF + LPO 6 
tablet was blended with 80 mg of LF + LPO powder (Orabarrier, Morinaga Milk 7 
Industry Co., Ltd, Tokyo, Japan) as active ingredient. Eighty mg of the LF + LPO 8 
powder contained 20 mg of LF, 2.6 mg (>25 units) of LPO and 2.6 mg (>25 units) of 9 
glucose oxidase, glucose and pH adjusting agents. A placebo tablet contained dextrin 10 
and coloring materials instead of the LF + LPO powder. The LF + LPO and placebo 11 
tablets were identical in weight, texture and appearance. 12 
 13 
Participants 14 
Forty-six individuals (31 nursing home residents and 15 healthy elders) exhibiting 15 
tongue coatings with no limitation of communication skills were invited to participate in 16 
this study, and informed consent was collected from all of them. 17 
 The exclusion criteria were as follows: 1) eating pureed and finely-chopped 18 
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meals; 2) receiving parenteral nutrition; 3) receiving treatment for dental disease (except 1 
adjustment of denture, oral hygiene instructions); 4) history of allergy to milk; 5) 2 
received antibiotic treatment in the past 1 month, or expected to receive it in the near 3 
future; 6) use of oral care products for prevention of oral malodor or improvement of 4 
oral hygiene; 7) regular consumption of LF or LPO-containing food or oral care 5 
products; and 8) presence of exacerbated diseases of the liver, kidney, heart, lung, 6 
gastro-intestine, blood, endocrine system, and metabolic system. The medication history, 7 
medical history, oral hygiene habits, and age of the patients were recorded. The 8 
participants were randomly assigned to oral administration of LF + LPO tablets (test 9 
group), or placebo tablets (placebo group). They were asked to lick the tablet after every 10 
meal for 8 weeks and record daily intake conditions.  11 
 12 
Randomization and blinding procedure 13 
     The independent registration center (Morinaga Milk Industry) registered and 14 
randomized the participants. The center generated a random sequence using computer 15 
by the permuted block method (block size of 4, stratification factor: tongue coating 16 
status, nursing home residents or healthy elders). The allocation sequence was 17 
concealed from study participants, the dentists and the authors. After all data were fixed, 18 
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the allocation sequence was broken. 1 
 2 
Oral and Bacteriological Assessments 3 
Oral and bacteriological assessments were conducted two hours after lunch at 4 
baseline, and after 4 and 8 weeks. Intake of combination treatments, pharmaceutical 5 
products and healthy food during the study period were also recorded. 6 
1) Oral Assessments 7 
Oral assessments were performed by three trained and calibrated dentists. The 8 
following oral assessments were conducted in all participants: plaque control record 9 
(PCR),14 probing pocket depth (PPD), bleeding on probing (BOP), tongue coating 10 
score,15 halitosis,16 and dry mouth.17 An oral moisture checking device (Mucus®, Life 11 
Co., Ltd., Saitama, Japan) was used to measure oral mucosa wettability of the buccal 12 
mucosa and tongue three times, and the average value was calculated. The presence of 13 
hydrogen sulfide (H2S), methylmercaptan (CH3SH), dimethyl sulfide ((CH3)2S) and 14 
total VSCs defined as the sum of H2S, CH3SH and (CH3)2S in a sample of mouth air 15 
was monitored using compact gas chromatography (Oral Chroma®, FIS Inc., Hyogo, 16 
Japan).18 17 
2) Bacteriological Assessments 18 
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After oral assessments, the tongue coating and supra-gingival plaque were 1 
collected using a sterile swab with constant pressure. The tongue coating was collected 2 
from a 2-cm2 area in the tongue center, and the supra-gingival plaque was taken from 3 
the cervical region on the buccal surface of maxillary molars. The swab was suspended 4 
in 1 ml of sterile saline stored in vials,19 and the number of periodontal pathogenic 5 
bacteria and total number of bacteria were measured using the PCR-Invader method.20 6 
 7 
Statistics Analysis 8 
The measured variables were expressed as mean ± SD and assessed using the 9 
Student’s t-test. Differences between the test and placebo groups were assessed by 10 
analysis of covariance, Wilcoxon rank sum test for ordinal data, and Fisher’s exact test 11 
for categorical data. The values of bacteriological assessments without P. gingivalis 12 
were compared using Student’s t-test. The bacteriological assessments of P. gingivalis 13 
using the Wilcoxon rank sum test, because normal distribution was not found in this 14 
data. The intra-group differences were analyzed using Student’s t-test and Wilcoxon 15 
signed-rank test for ordinal data. The correlation between the results of the oral 16 
assessments and the number of bacteria was also assessed. All analyses were performed 17 
according to the Full analysis set principle. The level of statistical significance was set 18 
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at p < 0.05. Statistical analysis was performed using the software program SPSS ver 19 1 
(SAS Institute Inc., North Caroline, US) 2 
 3 
Results 4 
The total study sample in the efficacy analysis consisted of 37 individuals, with 5 
20 in the test group (8 males, 12 females; mean age, 80.4 ± 6.4 years; range: 71–93 6 
years) and 17 in the placebo group (4 males, 13 females; mean age, 85.9 ± 6.7 years; 7 
range: 71–96 years). A flowchart of the number of participants at each stage is shown in 8 
Figure 1. One subject in the test group withdrew from the study before completion of 9 
the 4-week test. Three subjects in the test group and five subjects in the placebo group 10 
failed to comply with the suggested intake rate (less than 75% of the recommended rate). 11 
Seven subjects used antibiotics during the study period and were considered as missing 12 
variables after taking antibiotics. 13 
 14 
Patient demographics  15 
Table 1 shows the patient demographics for each group. Although the test group 16 
was significantly lower in age, no significant differences in gender and number of 17 
remaining teeth were observed between the two groups. No significant difference in the 18 
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rate of ingestion of test food was observed between the two groups.  1 
 2 
Bacteriological Assessments 3 
1) The number of bacteria in the supra-gingival plaque (Figure 2) 4 
A significant inter-group difference was observed the change in the number of P. 5 
gingivalis at 8 weeks, with the test group exhibiting lower values than the placebo group 6 
(p < 0.05). In addition, the total number of bacteria and the number of P. gingivalis was 7 
significantly reduced at 8 weeks compared to the baseline in the test group (p < 0.01 and 8 
p < 0.05, respectively). In the placebo group, the number of F. nucleatum was 9 
significantly increased at 4 weeks (p < 0.05). 10 
 11 
2) The number of bacteria in the tongue coating (Figure 3) 12 
In the test group, the total number of bacteria in the tongue coating was 13 
significantly reduced at 4 and 8 weeks compared with that at baseline (p < 0.05 and p < 14 
0.01, respectively), and the number of P. gingivalis and F. nucleatum were significantly 15 
reduced at 8 weeks (p < 0.05). In the placebo group, the total number of bacteria at 8 16 
weeks was significantly reduced compared with that at baseline (p < 0.01). 17 
 18 
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Oral assessments (Table 2) 1 
The PCR analysis showed no significant reduction in the test and the placebo 2 
group. PPD was significantly reduced at 8 weeks in both groups (p < 0.05), and BOP 3 
was significantly reduced in the test group at 8 weeks and in the placebo group at 4 4 
weeks (p < 0.05). The tongue coating score was significantly decreased at 4 and 8 5 
weeks in both groups (p < 0.01), but no significant differences were observed between 6 
the groups. No significant differences in the diagnosis of dry mouth were observed 7 
between the two groups. Measurement of buccal mucosa and tongue wettability was 8 
significantly reduced at 8 weeks in both groups (p < 0.05), but no differences were 9 
observed between the two groups. Oral malodor assessment by gas chromatography 10 
showed lower mean values and large SD of VSCs concentration in both groups, and 11 
absence in half of the subjects. No significant differences in the subjective evaluation of 12 
halitosis were observed between the two groups. 13 
 14 
Safety 15 
     No adverse events related to the test and placebo tablets were observed in all of 16 
participants during the study. 17 
 18 
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Analysis of searching 1 
A strong positive correlation was observed between the change in concentration 2 
of CH3SH and total VSCs concentration and the number of P. gingivalis in the tongue 3 
coating (r = 0.83, p < 0.01 and r = 0.782, p < 0.01, respectively). 4 
 5 
Discussion 6 
We examined the effects of continued ingestion of LF + LPO tablets for 8 weeks 7 
on the oral hygiene of older individuals using oral and bacteriological assessments. 8 
Although, we made the readily soluble perforated tablet, we do not assume that all 9 
nursing home residents are able to use this tablet. We chose participants who has a 10 
certain level of motor functions and who can eat food with normal or cut form. In the 11 
safety analysis, no adverse events were noted upon ingestion of the tablet, similar to 12 
Shimizu et al.13 13 
These proteins are present in exocrine fluids such as human saliva and milk, and 14 
are known to have antimicrobial effects against periodontal pathogenic bacteria such as 15 
Porphyromonas gingivalis,21, 22 as well as anti-inflammatory effects.10,23 16 
The results of the previous clinical trial involving ingestion of two LF + LPO 17 
tablets (LF: 100 mg/tablet; LPO: 1.8 mg/tablet) every hour showed a suppressive effect 18 
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on oral malodor and an influence on oral bacteria.12 Ingestion of the tablets (LF 300 1 
mg/day, LPO 5.4 mg/day) for three months resulted in a significant reduction in the 2 
plaque index score, 13 improvement in the effects of saliva, and reduction in the number 3 
of Fusobacterium in the subgingival plaque. These previous clinical studies examining 4 
LF and LPO-containing oral hygiene products (gels, toothpaste, and mouthwash) 5 
reported effects such as reduction in the number of periodontal pathogenic bacteria and 6 
candidial species on the mucosal lesion surface,24 and treatment of oral candidiasis.25 7 
 8 
Patient demographics 9 
In Table 1, the test group was significantly lower than placebo group in age. The 10 
following contents were considered as a reason. When we stratified participants at the 11 
randomization, lay emphasis on the tongue coating and the balance of nursing home 12 
residents and healthy elders. Therefore, the cause of the difference in age was the fact 13 
we were not able to lie emphasis on the age. Furthermore, the difference has become 14 
larger by the appearance of the dropout. In future, we should increase the number of 15 
participants, or should be stratified with an emphasis on age by changing the priorities 16 
at the time of randomization. 17 
 18 
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Bacteriological Assessments 1 
The reasons that we paid attention to the tongue coating and supra-gingival plaque 2 
are following. First, we can evaluate the tongue coating even in the edentulous subjects. 3 
Secondly we thought that significant influence to the tongue coating would be given to 4 
lick the tablet. Thirdly, Ximnez-Fyvie LA et al.,26 mentioned that the periodontal 5 
pathogenic bacteria on the supra-gingival plaque could spread or cause reinfection to the 6 
subgingival sites. 7 
 8 
The number of bacteria in the supra-gingival plaque 9 
There was a significant reduction in the number of P. gingivalis in supra-gingival 10 
plaque upon continued ingestion of LF + LPO tablets, and an inter-group difference was 11 
observed in the change in the number of P. gingivalis at 8 weeks. This is the first study 12 
that has exhibited this difference in the number of periodontal bacteria in supra-gingival 13 
plaque observed. Although the amount of LF and LPO in the tablets used in this study 14 
(LF: 20.0 mg/tablet, LPO: 2.6 mg/tablet) was less than that used in previous clinical 15 
trials (LF: 100 mg/tablet, LPO: 1.8 mg/tablet),12 its inhibitory effect on periodontal 16 
pathogenic bacteria was confirmed. It was suggested that the antimicrobial component 17 
of the tablet could more easily access the tongue coating and supra-gingival plaque than 18 
Page 16 of 31
GGI Editorial office (Email: ggi@blackwellpublishingasia.com)
Geriatrics and Gerontology International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
17 
 
subgingival plaque. LF has a bacteriostatic action on P. gingivalis by binding to 1 
hemoglobin receptor removing it from the cell surface, and consequently disrupting the 2 
iron uptake system of hemoglobin.21 The LPO system exhibits a bactericidal action 3 
against gram-negative bacteria and a bacteriostatic action against gram-positive bacteria. 4 
The results of this study exhibited the effects of LF + LPO tablets on periodontal 5 
pathogenic bacteria, and these were consistent with previous reports. In the results of 6 
the bacteriological assessment, items exhibiting statistically significant changes were 7 
fewer 4 weeks, and increased by 8 weeks upon long-term ingestion of LF + LPO tablets. 8 
Therefore, it was suggested that the antimicrobial activity of LF + LPO tablets against 9 
bacteria present in supra-gingival plaque became apparent after a certain period of 10 
consumption. 11 
 12 
The number of bacteria in the tongue coating 13 
A previous clinical trial examining LF and LPO did not takes its effects on the 14 
tongue coating into consideration. The total number of bacteria in the tongue coating 15 
decreased at 8 weeks in both groups, but the decrease in the number of P. gingivalis and 16 
F. nucleatum at 8 weeks was only observed in the test group. This could be explained by 17 
the antimicrobial action of LF and LPO. 18 
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It has been reported that tongue coating is significantly associated with oral 1 
malodor,27 and 60% of the total VSCs is produced by it.28 LF + LPO tablets had a 2 
inhibitory effect on halitosis within a short period of time in healthy adults,11 with the 3 
LPO system suppressing the production of VSCs using its antimicrobial effects and 4 
inactivation of the bacterial lyases of F. nucleatum and P. gingivalis.29 As we were 5 
unable to control the food and drinks consumed by the participants of this study, the 6 
VSCs component gas concentration at baseline was low and did not allow evaluation of 7 
the influence of the intervention on oral malodor. However, a strong positive correlation 8 
between the change in number of P. gingivalis in the tongue coating and the change in 9 
total VSCs was observed, suggesting a clinical association between the number of P. 10 
gingivalis in tongue coating and oral malodor. 11 
 12 
The tongue coating score 13 
The tongue coating score was significantly improved at 4 and 8 weeks in both 14 
groups. The tongue coating comprises oral microorganisms, and pathogenic bacteria 15 
reside beneath the epithelium and salivary components.30 It is removed in part by 16 
abrasion and auto-purification of the tongue surface by food. In this study, regardless of 17 
the components of the tablet, mechanical stimulation upon licking the perforated tablets 18 
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had an effect on reducing the tongue coating. We consider that this beneficial effect was 1 
exhibited in the process of dissolving of the tablet with tongue movement. Although we 2 
did not carry out a quantitative evaluation of lingual motor function in this trial, we 3 
chose participants who can eat food with normal or cut form by exclusion criteria. 4 
Therefore, tongue cleaning using a tablet could be useful as a simple method with less 5 
stimulation than the other instruments for healthy elderly people who have a certain 6 
level of oral functions. 7 
 8 
Oral assessments 9 
In table 2, PPD and BOP were decreased in each test group and placebo group. We 10 
suggested that these were improved by the influence of Hawthorne effect. It is positive 11 
bias that participants are encouraged to do tooth brushing by they met dentists several 12 
times. Therefore, this positive bias influenced both groups. Although anti-microbial 13 
effects on supra-gingival plaque and tongue coating was confirmed, no significant 14 
differences were observed in PCR, PPD, BOP, diagnosis of dry mouth, measurement of 15 
buccal mucosa, and tongue wettability between the groups. Because most of participants 16 
in the current study had a few number of remaining teeth, we did not accurately 17 
evaluated the effect on periodontal status. Future studies are required to elucidate the 18 
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detailed mechanism and further effects of these proteins on the oral hygiene status in the 1 
other generations. 2 
In conclusion, LF + LPO tablet ingestion exhibited antibacterial effects on 3 
periodontal bacteria present in the tongue coating and supra-gingival plaque. Needless 4 
to say, tooth brushing is necessary for oral self-care. We consider that this tablet could 5 
help them who are not able to do tooth brushing appropriately. Therefore, we expect that 6 
long-term ingestion may improve the oral hygiene of older individuals as a food and 7 
one of the supporting method. 8 
 9 
Acknowledgments 10 
The authors are thankful to staff of the Department of Special Needs Dentistry, 11 
Division of Hygiene and Oral Health, Showa University School of Dentistry for their 12 
great contributions. A part of this work was supported by a Research Grant for 13 
Longevity Sciences (25-7) from of the Ministry of Health, Labour and Welfare, Japan. 14 
 15 
Disclosure statement 16 
     This study was supported by research grants from Morinaga Milk Industry Co., 17 
Ltd. Four of the authors, M. Nakano, H, Wakabayashi, K. Yamauchi, and F. Abe are 18 
Page 20 of 31
GGI Editorial office (Email: ggi@blackwellpublishingasia.com)
Geriatrics and Gerontology International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
21 
 
employees of Morinaga Milk Industry Co., Ltd. The other authors declares no potential 1 
conflicts of interest. 2 
 3 
References 4 
1 Statistics Bureau, MIC; Ministry of Health, Labour and Welfare; Ministry of L and, 5 
Infrastructure, Transport and Tourism. Available at 6 
http://www.stat.go.jp/english/data/handbook/c0117.htm#c02 Accessed August 25, 2015 7 
2 Vital Statistics in JAPAN -The latest trends- Ministry of Health, Labour and 8 
Welfare. Available at http://www.mhlw.go.jp/english/database/db-hw/vs01.html 9 
Accessed August 25 2015 10 
3 Teramoto S. Current Definition of Aspiration pneumonia: An Overview. The 11 
Japanese Journal of Chest Diseases 2009; 68: 795–807 12 
4 Yoneyama T, Yoshida M, Matsui T, Sasaki H. Oral care and pneumonia. Lancet 13 
1999; 354: 515. 14 
5 Susana AG, Sigifredo AG, Quintin Rascon C. Lactoferrin: structure, function and 15 
applications. Int J Antimicrob Agents 2009; 33(4): 301.e1-301.e8 16 
6 Wakabayashi H, Kondo I, Kobayashi T, et al. Periodontitis, periodontopathic 17 
bacteria and lactoferrin. Biomaterial 2010; 23: 419–424. 18 
7 Lönnerdal B, lyer S. Lactoferrin: molecular structure and biological function. Annu 19 
Page 21 of 31
GGI Editorial office (Email: ggi@blackwellpublishingasia.com)
Geriatrics and Gerontology International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
22 
 
Rev Nutr 1995; 15: 93–110. 1 
8 Wakabayashi H, Yamauchi K, Kobayashi T, Yaeshima T, Iwatsuki K, Yoshie H. 2 
Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas 3 
gingivalis and Prevotella intermedia. Antimicrob Agents Chemother 2009; 53: 3308–4 
3316 5 
9 Komatsu A, Satoh T, Wakabayashi H, Ikeda F. Effects of bovine Lactoferrin to oral 6 
Candida albicans and Candida glabrata isolates recovered from the saliva in elderly  7 
people. Odontology 2013; 103: 50–55 8 
10 Thomas EL, Bozeman PM, Learn DB. Lactoperoxidase: structure and catalytic 9 
properties. Peroxidases in Chemistry and Biology, Everse J, Everse K E, and Grisham 10 
M B, Eds. 1991; vol.1, 123-142, CRC, Boca Raton, Fla, USA. 11 
11 Shin K, Horigome A, Wakabayashi H, Yamauchi K, Yaeshima T, Iwatsuki K. In 12 
vitro and vivo effects of a composition containing lactoperoxidase on oral bacteria and 13 
breath odor. J Breath Res 2008; 2: 017014(5 pp). 14 
12 Shin K, Yaegaki K, Murata T, et al. Effect of a composition containing lactoferrin 15 
and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, 16 
crossover, placebo-controlled clinical trial. Clin Oral Invest 2011; 15: 485–493. 17 
13 Shimizu E, Kobayashi T, Wakabayashi H, Yamauchi K, Iwatsuki K, Yoshie H. 18 
Page 22 of 31
GGI Editorial office (Email: ggi@blackwellpublishingasia.com)
Geriatrics and Gerontology International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
23 
 
Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on 1 
Clinical and Bacteriological Profiles in Chronic Periodontitis Patients. Int J Dent 2011; 2 
405139(9 pages). 3 
14 O’Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontal  4 
1972; 43: 38. 5 
15 Miyazaki H, Sakao S, Katoh Y, Takehara T. Correlation Between Volatile  6 
Sulphur Compounds and Certain Oral Health Measurements in the General Population.  7 
J Periodontal 1995; 66: 679–684. 8 
16 Miyazaki H, Arao M, Okamura K, et al. Tentative Classification for Halitosis 9 
Patients and Its Treatment Needs. Niigata Dent J 1999; 29: 11–15. 10 
17 Kakinoki Y, Nishihara T, Aruta M, Shibuya K, Ishikawa M. Usefulness of new 11 
wetness tester for diagnosis of dry mouth in disabled patients. Gerodontorogy 2004; 12 
21: 229–231. 13 
18 Morita M, Wang HL. Relationship Between Sulcular Sulfide Level and Oral  14 
Malodor in Subjects With Periodontal Disease. J Periodontol 2001; 72: 79–84. 15 
19 Cortelli JR, Aquino DR, Cortelli SC, et al. Etiological Analysis of Initial 16 
Colonization of Periodontal Pathogens in Oral Cavity. J Clin Microbiol 2008; 46: 17 
1322–1329. 18 
Page 23 of 31
GGI Editorial office (Email: ggi@blackwellpublishingasia.com)
Geriatrics and Gerontology International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
24 
 
20  Tadokoro K, Yamaguchi T, Kawamura K, et al. Rapid quantification of 1 
periodontitis-related bacteria using a novel modification of Invader PLUS technologies. 2 
Microbiol Res 2010; 165: 43–49 3 
21 Shi Y, Kong W, Nakayama K. Human lactoferrin binds and removes the 4 
hemoglobin receptor protein of the periodontopathogen Porphromonas gingivalis. J 5 
Biol Chem 2000; 275: 30002–30008. 6 
22 Ihalin R, Loimaranta V, Lenander-Lumikari M, Tenovuo J. The sensitivity of 7 
Porphromonas gingivalis and Fusobacterium nucleatum to different (pseudo) 8 
halide-peroxidase combinations compared with mutans streptococci. J Med Microbiol 9 
2001; 50: 42–48. 10 
23 Levay PF, Viljoen M. LACTOFFERRIN: A general review. Haematologica 1995; 11 
80: 252–267 12 
24 Nagy K, Urban E, Fazekas O, Thurzo L, Nagy E. Controlled Study of 13 
Lactoperoxidase Gel on Oral Flora and Saliva in Irradiated Patients With Oral Cancer. J 14 
Craniofac Surg 2007; 18: 1157–1164. 15 
25 Masci JR. Complete response of severe of severe, refractory oral candidiasis to 16 
mouthwash containing lactoferrin and lysozyme. AIDS 2000; 14: 2403–2404. 17 
26 Ximnez-Fyvie LA, Haffajee AD, Socransky SS. Microbial composition of supra- 18 
Page 24 of 31
GGI Editorial office (Email: ggi@blackwellpublishingasia.com)
Geriatrics and Gerontology International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
25 
 
and subgingival plaque in subjects with adult periodontitis. J clin Periodontal 2000; 27: 1 
722-732 2 
27 Pham TA. Comparison between self-estimated and clinical oral malodor. Acta 3 
Odontol Scand 2013; 71: 263–270. 4 
28 Yaegaki K, Sanada K. Biological and clinical factors influencing oral malodor in 5 
periodontal patients. J Periodontal 1992; 63: 783–789. 6 
29 Nakano M, Shin K, Wakabayashi H, Yamauchi K, Abe F, Hironaka S. Inactivating 7 
effects of the lactoperoxidase system on bacterial lyases involved in oral malodor 8 
production. J Med Microbiol 2015; 64: 1244-1252. 9 
30 Matsui K, Chosa N, Shimoyama Y, Minami K, Kimura S, Kishi M. Effects of 10 
tongue cleaning on bacterial flora in tongue coating and dental plaque: a crossover study. 11 
BMC Oral Health 2014; 14: 4 12 
 13 
 14 
 15 
 16 
 17 
 18 
Page 25 of 31
GGI Editorial office (Email: ggi@blackwellpublishingasia.com)
Geriatrics and Gerontology International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
26 
 
Figure legends: 1 
Figure 1: Flowchart of participants through each stage of the randomized trial. 2 
 3 
Figure 2: In the supragingival plaque, effect of the test tablet on the number of bacteria  4 
Test group: n= 14, placebo group: n= 10. 5 
Total number of bacteria (a), Number of P. gingivalis (b), Number of F. nucleatum (c),   6 
Change in the total number of bacteria (d), Change in the number of P. gingivalis (e), 7 
Change in the number of F. nucleatum (f).  8 
#: p < 0.05 signficant difference between the test and placebo group, as identified by 9 
Wilcoxon rank sum test. 10 
*: p < 0.05, **: p < 0.01. There is a significant difference compared to before ingestion. 11 
 12 
Figure 3: In the tongue coating, effect of the test tablet on the number of bacteria 13 
Test group: n= 16, placebo group: n= 14. 14 
Total number of bacteria (a), Number of P. gingivalis (b), Number of F. nucleatum (c),   15 
Change in the total number of bacteria (d), Change in the number of P. gingivalis (e), 16 
Change in the number of F. nucleatum (f). 17 
*: p < 0.05, **: p < 0.01. There is a significant difference compared to before ingestion. 18 
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